CODX | Co-Diagnostics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.7603 - 0.8000
52 Week Range	0.6700 - 2.2300
Beta	1.39
Implied Volatility	524.31%
IV Rank	66.03%
Day's Volume	69,984
Average Volume	192,545
Shares Outstanding	31,929,800
Market Cap	25,256,472
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2017-07-12

Valuation
Profitability
Growth
Health
P/E Ratio	-0.57
Forward P/E Ratio	-253.00
EPS	-1.38
1YR Price Target	6.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	155
Country	USA
Website	CODX

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

CODX's peers: HSCS, NAOV, RPID, THMO, BMRA, NMRD, BJDX, MOVE, INVO, NVNO, TIVC, BBLG, VVOS, SENS, INGN, CLPT, NPCE, SRDX, CVRX, NURO, RSLS, IINN, OPGN, VXRT

*Chart delayed

Analyzing fundamentals for CODX we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is very good and Health is weak. For more detailed analysis please see CODX Fundamentals page.

Watching at CODX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on CODX Technicals page.